PA
CNMD icon

Pinnacle Associates’s CONMED CNMD Stock Holding History

Pinnacle Associates’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-8,070
Closed -$356K – 658
2016
Q4 		$356K Sell
8,070
-1,600
-17% -$68K 0.01% 532
2016
Q3 		$387K Sell
9,670
-11,575
-54% -$491K 0.01% 503
2016
Q2 		$1.01M Sell
21,245
-4,650
-18% -$197K 0.02% 367
2016
Q1 		$1.09M Sell
25,895
-15,340
-37% -$602K 0.02% 354
2015
Q4 		$1.82M Sell
41,235
-76,310
-65% -$3.31M 0.04% 286
2015
Q3 		$5.61M Sell
117,545
-1,350
-1% -$74.1K 0.12% 174
2015
Q2 		$6.93M Sell
118,895
-4,030
-3% -$217K 0.13% 163
2015
Q1 		$6.21M Buy
122,925
+825
+0.7% +$40.4K 0.12% 176
2014
Q4 		$5.49M Buy
+122,100
New +$5.12M 0.11% 184

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Pinnacle Associates's CNMD Position: Q1 2017 in Review

Pinnacle Associates sold out of CONMED (CNMD) in Q1 2017, closing a stake of 8,070 shares — an estimated $356K sold.

Pinnacle Associates first reported a position in CNMD in Q4 2014 and held it in 9 quarters. The position peaked at $6.93M in Q2 2015. 142 funds tracked by Wall St. Rank hold CNMD as of Q1 2017.

  • Pinnacle Associates reported no remaining CONMED position as of Q1 2017 after selling out during the quarter.
  • Pinnacle Associates sold 8,070 CONMED shares in Q1 2017, an estimated $356K.
  • Pinnacle Associates first reported a position in CONMED in Q4 2014 and held it in 9 quarters.
  • Pinnacle Associates's CONMED position peaked at $6.93M in Q2 2015.
  • 142 funds tracked by Wall St. Rank held CONMED as of Q1 2017.

Based on Pinnacle Associates's 13F filing for Q1 2017, filed 10 May 2017.